128 related articles for article (PubMed ID: 33374094)
21. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
[TBL] [Abstract][Full Text] [Related]
22. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.
Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
Diabetes Technol Ther; 2019 Apr; 21(4):201-208. PubMed ID: 30901232
[TBL] [Abstract][Full Text] [Related]
24. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study.
Ziegler R; Rees C; Jacobs N; Parkin CG; Lyden MR; Petersen B; Wagner RS
Pediatr Diabetes; 2016 Aug; 17(5):311-8. PubMed ID: 26073672
[TBL] [Abstract][Full Text] [Related]
25. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
26. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
Klinkert C; Bachran R; Heidtmann B; Grabert M; Holl RW;
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):118-22. PubMed ID: 17973210
[TBL] [Abstract][Full Text] [Related]
27. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
28. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.
King AB; Clark D; Wolfe GS
Diabetes Technol Ther; 2012 Oct; 14(10):900-3. PubMed ID: 22845649
[TBL] [Abstract][Full Text] [Related]
29. Asymmetric changes in circulating insulin levels after an increase compared with a reduction in insulin pump basal rate in people with Type 1 diabetes.
McAuley SA; Ward GM; Horsburgh JC; Gooley JL; Jenkins AJ; MacIsaac RJ; O'Neal DN
Diabet Med; 2017 Aug; 34(8):1158-1164. PubMed ID: 28453877
[TBL] [Abstract][Full Text] [Related]
30. Treatment of type 1 diabetes in children and adolescents using modern insulin pumps.
Kordonouri O; Hartmann R; Danne T
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S118-24. PubMed ID: 21864743
[TBL] [Abstract][Full Text] [Related]
31. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
[TBL] [Abstract][Full Text] [Related]
32. Bolus Calculator Settings in Well-Controlled Prepubertal Children Using Insulin Pumps Are Characterized by Low Insulin to Carbohydrate Ratios and Short Duration of Insulin Action Time.
Hanas R; Adolfsson P
J Diabetes Sci Technol; 2017 Mar; 11(2):247-252. PubMed ID: 27470666
[TBL] [Abstract][Full Text] [Related]
33. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry.
Kamrath C; Tittel SR; Kapellen TM; von dem Berge T; Heidtmann B; Nagl K; Menzel U; Pötzsch S; Konrad K; Holl RW
Lancet Child Adolesc Health; 2021 Jan; 5(1):17-25. PubMed ID: 33253630
[TBL] [Abstract][Full Text] [Related]
34. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
35. Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps.
Holterhus PM; Bokelmann J; Riepe F; Heidtmann B; Wagner V; Rami-Merhar B; Kapellen T; Raile K; Quester W; Holl RW;
Diabetes Care; 2013 Jun; 36(6):1507-11. PubMed ID: 23404300
[TBL] [Abstract][Full Text] [Related]
36. Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes.
Andersen AJ; Ostenfeld A; Pipper CB; Olsen BS; Hertz AM; Jørgensen LK; Høgsmose J; Svensson J
Diabet Med; 2016 Oct; 33(10):1360-5. PubMed ID: 26773826
[TBL] [Abstract][Full Text] [Related]
37. The Predictive Low Glucose Management System in Prevention of Clinically Significant Hypoglycemia in Type 1 Diabetes. A Preliminary Study Identifying the Most Common Events Leading Up to Hypoglycemia During Insulin Pump Therapy.
Thomakos P; Mitrakou A; Kepaptsoglou O; Taraoune I; Barreto C; Zoupas CS
Exp Clin Endocrinol Diabetes; 2021 May; 129(5):385-389. PubMed ID: 30986882
[TBL] [Abstract][Full Text] [Related]
38. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
[TBL] [Abstract][Full Text] [Related]
39. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
[TBL] [Abstract][Full Text] [Related]
40. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
